TARA Protara Therapeutics, Inc.
Healthcare$4.67+0.00%OpenMarket Cap: $180.1M
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$12.00
Target (Median)
$12.00
Target Range
$12.00 - $12.00
Upside from current price: 157.1%
Rating Distribution
2 Strong Buy6 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-20 | Oppenheimer | maintain | Outperform | Outperform |
| 2026-05-14 | JP Morgan | maintain | Overweight | Overweight |
| 2026-04-29 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-02-10 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-12-03 | HC Wainwright & Co. | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-1.46 | $1.2M | 6 |
| Sun Dec 31 | $-0.60 | $82.3M | 4 |
| Mon Dec 31 | $0.48 | $205.4M | 2 |
| Tue Dec 31 | $1.49 | $340.1M | 2 |